Mumbai: As global trade uncertainties, tariff wars, and geopolitical disruptions continue to reshape the healthcare landscape, industry leaders at the recently concluded ETPharma Future Ready Supply Chain Summit emphasized the urgent need for resilient, diversified, and sustainable supply chain strategies across the pharma, medical device, and biopharma sectors.

The high-powered panel discussion, titled “Tariffs & Sustainability: Adapting Pharma, Medical Device & BioPharma Supply Chains to New Global Realities,” featured top finance leaders including Dipesh Vora, CFO, Dräger; Aditi Pai, CFO, Transasia Bio-Medicals Ltd; and Chandrachur Datta, Partner, Vector Consulting Group. The session was moderated by Vikas Dandekar, Editor, ETPharma.

Opening the discussion, Pai underscored the diagnos

See Full Page